9999999997-14-000715.txt : 20140207 9999999997-14-000715.hdr.sgml : 20140207 20140207143418 ACCESSION NUMBER: 9999999997-14-000715 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140207 DATE AS OF CHANGE: 20140207 20140207 20140207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 14583704 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-"B6UM;6U#0HQ(#`@;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V5S+T-O=6YT(#$O2VED'0O26UA9V5"+TEM86=E0R]);6%G94E=(#X^+TUE9&EA0F]X6R`P(#`@-C$R M(#2]#4R]$979I8V521T(^/B]486)S+U,O4W1R=6-T4&%R96YT M)R=6FMO&[L1_1[`_X%`OTB`O5F^ M]E%<7,"1G5P7M5W8"E"@*0K)DJ(%]+IZW)OTUW>&NY27NSOK<1/`MNS#X3P. M9\@AQ<=_B%]^^7@_NKL1\:^_BD\W(_%I?/'AXV1[$R M(HVS*$_$>'WQ(1;?\@UQ'8Y-E&1U"+1>91[(9]1O3FH,44%]O##"7^8[%&]GR*]%"J6AG*O MR:,L#07V:I5T:%7Q.%$)DWAI5XP2&1DE$JE>B??X='/[)+X,\\'3-5KS,+Y[ MP`B(X54^&#T^@.G@\IO;AS&&Y.[Z[\)1Z@DB)&-@UOVP"C$`B*C8.+(VG+57 M]:Q+]7+%V3QKT!VU'_]V)IIXFW-DF&P4I^$,UR,0X0P7CY_!1:"&UI29,L%5 M%(SO-3.GPVPSPV2PC+LH;%24Y,*F\2OCKO?#9/!]>R"T5ZF.5&,(Y2D%2[V) M=4Y:HG]QF>`*F>S\)[=6CL7+T`ZHZ;7142)#D9?B;H-4>P$1$34NR2,M:;7; M_NK)ZM:FS,4EN]*Z4B:R0"`P10>)HUAY3XB';41Z%=*OD>%P3;)-93:R.D1? MD=@\,GF(!2)+G5)>5;8U@%PV*FMA*46T5I&Q3+F0RYO8T?`J+5WZ%[*4@1,; M;M%Q#WE:X#RGT%F*:8Q4ODV2SK(-PY%J*H^LK*3\Q_^CXI>G]!AZ&)J'":T^ MK%]A$^RE%+&7LM)BHN,([*JO7DH,9;9+2I#UH=S%*L1"(H.D\'T(U8?,9M+: M2#.G@'U4`SI>SB%5P33)8`*+=N=RV+'`18RYB$RA*HZ4#45=NC)ZAS5T@S_U MY3)EC,N!'*V52:.TH?;A-%UC%BZ.+M_.9V("*7\CG`V[U5E__%Q:L]V(TV;F M$C:Y#*&^Z2_ M.0()(&EV18=&JQI`;P.9D386N7A]@?Z.)E,2V5/:!;P&..A>(SV`(& MZ0&IK$E@Q>M0(G5N,:F*TH:_J-)C\'C2L$I2V$RUL*2^4(?3!D46Q0JB\@:G M4H/5I!P`H:6R4VPQ`0;HFSEX\87,F"92C0%(PO74<;#]"K"?JH1P MF`/O9P)C#0O$Y8F=JS%S_\?-T2WS`T0*#AQ3A/T<*CH]J03.[3J<[1I3@Q/; M7R%5#ML8S;-*Y4D+^W_62`W55J6AJ*I&;E[`(^0^/W/9GZ6NSFP+>UQ.CF35 MTFS16.':HIW5!\CKBS*WES_>`17\7DY5PDSM?+HK-!*N3_TOAUOYF`7^O:XBU'P4(5PW< MUCH95)2\LF[&&925[>(M6V3^FOQ>]SI!Z;I&78Z7PHJOD3N&1R-'\PA.7>K; M`)2:?AO"UV\#`]\3((57ZJ;XHSBX?0V(`5U&V_UNNV_N8U!UL'KC*Z,[;2U1 M#;?VQ&Q^=(1=%YMR';YA$N3=<^;9;(]E<=^*W6GZNI%:.;?^'&I8HK/B\++: M'LY)5I2[L$B@Y4FY:T#7SZ#Z(\:M3A"@9+G&+P6.^N'WB&5A1V,*\GSDSJRA MHLT(+]!/$$*GR]+IY2`K5!V^_UFP-D`ZEZ\9]*SGN<:3R5!'-AQ+[M?A$"FS M$$OF6"U;V#\+YTYWSA88KNE<(+-1U]5\XM9G&?;CMNZ,()SB[#W'O2/:6)QW M<<*EN'VQG?7LA3337DQ1L,MAV:MA:]'$'G9SS)8%)(O97\EFJ,%=##E'N_IU M]=T\`]*4>^;K:6OIQ+#/?#QLHOA8.,DTL;<_,+4Z(B>PL:;J'RPU8\.1,B;W M+E:VT;:GA$-I91F@TAA7/`M;=;1X6#A9-;''Y7Y[^HZ=EB7-2X6E/!CV[%?+ M[CA?3UT5H7:;6``3IN5&)RVLVVWB$HU)YYHT0^J34[0O:[J:J9Z[-L9(\;C+ MPE;<96$K[M:Q#>X"(25U=O8LXTSE6<;!>I:QL!7+ZMAWL*P^[&'[!U;&\E@S MIPFFHESRE,.+HR96*D\P1;;\TS(U4U.T"=;5??8$`Y);+L%8V(I@+&Q%L#JV M@V!4P]@3C#.5)Q@'ZPG&PE8$JV/?0;#ZL/<1C*.<)U@=^PZ"45.T"=9U,>$) MIA3V#'D$8V$K@K&P%<'JV`Z"96\0C#.5)Q@'ZPG&PE8$JV/?0;#ZL/<1C*.< M)U@=*Q79'TU;8,_%_KY<*)_LU5:TI11OT[;KJL33%I]N<&G+PE:T96$KVM:Q M';2E[HP\;3E3>=IRL)ZV+&Q%VSKV';2M#WL?;3G*>=K6L6_2M@YFTC:0_Q9M M*<7;M.UZ"%/15N&#!29M>=B2MCQL2=L`VZ:MHAQ=T98U545;%K:B+0];TC;` M\FD;#+OQI/6-(48SW&B)-QLL5?&DW<0J]R8(J=E3W-V5!#E%FVX]UZD*'Y-Q MZ<;"5G1C82NZ<;`*G(5Q96$K;G&PGELL;,4M"MOV?,_U`K[;X.[;`^SY,LRU MFT9;=WF[+IO)AZJO2=X4@A/S4-QE_<;@Z`A>-KG>UT!]\4?X2[$[[0\G=X=\ M[G_V]PD5/KSS^LS*YANN/==C=+-53V?A-C^H/;<]BA\K,>3TM,U4_A:CR>EIVNF\.$<2XKNZ5_@&N72E(XC]S;P_K3?+9'7 M%(_Q04+:,W<[DCV-`HF/`YF!Y$"K.'*@51@94!]%#K0*(@/J8\B!5B&L0<_= M2=P'N`O8XZ2Z+I4)&3M\]V4T:TXC#;ZXHJ#M*/>7!E+T9O M;G0O4W5B='EP92]47!E+T9O;G1$97-C^&%F=N%DI.9O.\S'WE) M!P4*P!(\`E:`!0'6@)Z!"OT)$`)Y#T3`10!B8%\""4A1Z0,07P,%=:M:(8&` M*@BHOAI""&J"4KF,4)8%,$&52`Q5*<`"M7K90UVJ).CH*N=2:Z4BG0VJA'4Z M6`4=$)"T4W2B5!<@.E/6B[#66B]4I+^BR1'G!JTYYI2X% MU5?ZM&1=YSB(KI73(+K*D,Q:JQK.SMQM$A=PY^;NUMV_OT0W'_K]8KCGZ8>O/PE)D(X)8ZFLU&.AP@I:(2MLQ7QZ M3AA+L&(4,@H9A8W"1F&CL%'8*&P4-@H;A8W"1A&CB%'$*&(4,8H818PB1A&C MR$AYA,/&'&W$?1_C7=<-[J[;QIOF)9T6TI;IAL5V?)K.#:EG_.@:YNCI++X- MU_$=\("^4E;;#='-TN6R77XV[E7ZU+VY>5P,[E=LEK&W^^3YN/_=;C=MG*^; M-,/4\:-50C-LNO;0[H?-WT9OQM:?KG]^ZKIG=]$M]CN=T]CSNHYQL'=^TRSZ M[JC]\B=7KR#^Q9W\H-"F5N9'-T7!E+UA2968O4VEZ92`U,B]76R`Q M(#0@,ET@+U)O;W0@,2`P(%(O26YF;R`Y(#`@4B])1%L\1#,X-S(V,C0W,C

)PUT+<1PF`,AF']QD1GFYQSQ0)LQ!+4E&S@RBMX!F9@&B/T M@@H]ISM]A22BU31.>R;RY0ZUX2HC>!CAU8@N\#;BEXBG@50.<(03[.&WC#``(((8(8$D@A@QP*&,((QC"!*F4@-3,O4F]O="`Q(#`@4B]);F9O(#D@,"!2+TE$ M6SQ$,S@W,C8R-#-3,R,#X^#0IS=&%R='AR968-"C8X-S4-"B4E14]& ` end